| ACET |    | Adicet Bio, Inc. - Common Stock | | | -5.68% up -7.22% 1.54 | | + Medicine, Cancer fight
| + My List |
| ADAP | | Adaptimmune Therapeutics plc - American Depositary Shares | | | 8.27% up 7.73% 0.54 | | + Medicine, Cancer fight
Last highlighted: #ADAP SEC report: Adaptimmune Therapeutics PLC Statement of changes in beneficial ownership of securities | + My List |
| AEMD | | Aethlon Medical, Inc. - Common Stock | | | -3.63% up -7.92% 4.29 | | + Health Devices, Medicine, Cancer fight
| + My List |
| AFMD | | Affimed N.V. - Common Stock | | | -7.12% down -5.43% -1.69 | | + Immunology, Cancer fight, Medicine
| + My List |
| AGEN | | Agenus Inc. - Common Stock | | | -4.95% up -7.38% 2.43 | | + Cancer fight, Immunology, Medicine
Last highlighted: #AGEN SEC report: AGENUS INC Statement of changes in beneficial ownership of securities | + My List |
| AIKI | | AIkido Pharma Inc. - Common Stock | | | -6.8% up -8.74% 1.94 | | + Cancer fight, Pharmaceutical , Medicine
Last highlighted: #AIKI SEC report: AIkido Pharma Inc. Current report, item 8.01
SEC Filing Form 8-K filed by AIkido Pharma Inc. -- SEC File Number 211098058 | + My List |
| AKER | | Akers Biosciences Inc. - Common Stock | | | -11% -11% 0 | | + Medicine, Pharmaceutical , Immunology, Cancer fight
| + My List |
| ALLO | | Allogene Therapeutics, Inc. - Common Stock | | | 12.04% 12.04% 0 | | + Cancer fight, Gene and cell, Medicine
| + My List |
| ALPN | | Alpine Immune Sciences, Inc. - Common Stock | | | 11.58% 11.58% 0 | | + Medicine, Cancer fight
| + My List |
| ALRN | | Aileron Therapeutics, Inc. - Common Stock | | | -6.84% up -7.69% 0.85 | | + Cancer fight, Medicine, Biopharma
| + My List |
| ALXO | | ALX Oncology Holdings Inc. - Common Stock | | | 5.32% up -7.69% 13.01 | | + Medicine, Cancer fight
| + My List |
| ANAB | | AnaptysBio, Inc. - Common Stock | | | -0.76% up -7.46% 6.7 | | + Immunology, Cancer fight, Medicine
| + My List |
| ANCN | | Anchiano Therapeutics Ltd. - American Depositary Shares | | | 0.00% 0 | | + Cancer fight, Biopharma, Medicine, Country: Israel
| + My List |
| ANIX | | Anixa Biosciences, Inc. - Common Stock | | | -4.35% down 10.65% -15 | | + Cancer fight, Medicine, Immunology
| + My List |
| ANPC | | AnPac Bio-Medical Science Co., Ltd. - American Depositary Shares | | | -2.50% -2.50% 0 | | + Cancer fight
Last highlighted: #ANPC SEC report: AnPac Bio-Medical Science Co., Ltd. [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
SEC Filing Form 20-F/A filed by AnPac Bio-Medical Science Co., Ltd. -- SEC File Number 211081601 | + My List |
| APOP | | Cellect Biotechnology Ltd. - American Depositary Shares | | | 7.92% up 6.97% 0.95 | | + Country: Israel, Cancer fight, Medicine
| + My List |
| APRE | | Aprea Therapeutics, Inc. - Common Stock | | | -6.81% up -8.6% 1.79 | | + Medicine, Cancer fight
Last highlighted: Aprea Therapeutics Inc trading halted, news pending
$APRE | + My List |
| ARAV | | Aravive, Inc. - Common Stock | | | 8.99% 8.99% 0 | | + Medicine, Cancer fight
| + My List |
| ATNX | | Athenex, Inc. - Common Stock | | | 6.60% 6.60% 0 | | + Cancer fight, Biopharma, Covid (fighting)
Last highlighted: $ATNX 📜 SEC Form 10-Q filed by Athenex, Inc.
https://t.co/1k3SCVGjG9
30 seconds delayed. | + My List |
| AUTL | | Autolus Therapeutics plc - American Depositary Shares | | | 7.32% up 5.2% 2.12 | | + Country: Greate Britain, Gene and cell, Cancer fight, Medicine
Last highlighted: $AUTL Autolus Therapeutics to Report First Quarter 2021 Financial Results and Host Conference Call on May 6
https://t.co/Bswi1mwqgf | + My List |
| AVCO | | Avalon GloboCare Corp. - Common Stock | | | up -15.24% 15.24 | | + Cancer fight, Medicine, Immunology, Pharmaceutical
Last highlighted: #AVCO SEC report: Avalon GloboCare Corp. Current report, items 1.01 and 9.01
SEC Filing Form 8-K filed by Avalon GloboCare Corp. -- SEC File Number 211089336 | + My List |
| AVEO | | AVEO Pharmaceuticals, Inc. - Common Stock | | | -5.58% up -7.21% 1.63 | | + Medicine, Disease: Oncology, Cancer fight
Last highlighted: #AVEO SEC report: AVEO PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by AVEO PHARMACEUTICALS, INC. -- SEC File Number 211148137 | + My List |
| AWH | | Aspira Women's Health Inc. - Common Stock | | | -2.84% up -7.09% 4.25 | | + Cancer fight, Women Health, Medicine
| + My List |
| AYLA | | Ayala Pharmaceuticals, Inc. - Common Stock | | | 1.31% up -7.56% 8.87 | | + Medicine, Cancer fight
| + My List |
| BLRX | | BioLineRx Ltd. - American Depositary Shares | | | -7.34% down -6.42% -0.92 | | + Medicine, Cancer fight
| + My List |
| BNGO | | Bionano Genomics, Inc. - Common Stock | | | 1.98% up -10.04% 12.02 | | + Medicine, Cancer fight, Gene and cell
Last highlighted: Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics https://t.co/Q8ywclbV2i | + My List |
| BNGOW | | Bionano Genomics, Inc. - Warrant | | | -11.01% -11.01% 0 | | + Cancer fight, Medicine, Gene and cell
| + My List |
| BNR | | Burning Rock Biotech Limited - American Depositary Shares | | | -6.26% up -9.09% 2.83 | | + Country: China, Cancer fight, Medicine
| + My List |
| BPTH | | Bio-Path Holdings, Inc. - Common Stock | | | 4.1% up -7.14% 11.24 | | + Cancer fight, Medicine
| + My List |
| BYSI | | BeyondSpring, Inc. - Ordinary Shares | | | 2.37% up -12.29% 14.66 | | + Cancer fight, Biopharma, Medicine, Immunology
Last highlighted: Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC $BYSI https://t.co/AH1YS5LVCR | + My List |
| CALA | | Calithera Biosciences, Inc. - Common Stock | | | -10% -10% 0 | | + Medicine, Cancer fight
| + My List |
| CBLI | | Cleveland BioLabs, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight
| + My List |
| CCXI | | ChemoCentryx, Inc. - Common Stock | | | -7.46% down -7.25% -0.21 | | + Biopharma, Cancer fight, Immunology, Medicine
Last highlighted: #CCXI SEC report: ChemoCentryx, Inc. Current report, items 7.01, 8.01, and 9.01 | + My List |
| CELC | | Celcuity Inc. - Common Stock | | | 0.94% up -7.6% 8.54 | | + Cancer fight, Medicine
Last highlighted: #CELC SEC report: Celcuity Inc. Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G filed by Celcuity Inc. -- SEC File Number 211081754 | + My List |
| CGIX | | Cancer Genetics, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight, Medicine
| + My List |
| CKPT | | Checkpoint Therapeutics, Inc. - Common Stock | | | up -9.57% 9.57 | | + Cancer fight, Medicine
| + My List |
| CLDX | | Celldex Therapeutics, Inc. - Common Stock | | | 3.31% up -10.72% 14.03 | | + Cancer fight, Immunology, Medicine
Last highlighted: #CLDX SEC report: Celldex Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Celldex Therapeutics, Inc. -- SEC File Number 211148052 | + My List |
| CLLS | | Cellectis S.A. - American Depositary Shares | | | 3.9% down 7.56% -3.66 | | + Biopharma, Medicine, Cancer fight
| + My List |
| CLRB | | Cellectar Biosciences, Inc. - Common Stock | | | -6.93% up -7.84% 0.91 | | + Medicine, Biopharma, Cancer fight
Last highlighted: #CLRB SEC report: Cellectar Biosciences, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Cellectar Biosciences, Inc. -- SEC File Number 211087932 | + My List |
| CLSN | | Celsion Corporation - Common Stock | | | 7.84% up 3.92% 3.92 | | + Cancer fight, Medicine
| + My List |
| CMPI | | Checkmate Pharmaceuticals, Inc. - Common Stock | | | -7.96% down -6.57% -1.39 | | + Cancer fight, Medicine, Pharmaceutical
Last highlighted: #CMPI SEC report: Checkmate Pharmaceuticals, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Checkmate Pharmaceuticals, Inc. -- SEC File Number 211142205 | + My List |
| CNST | | Constellation Pharmaceuticals, Inc. - Common Stock | | | 65.42% down 65.56% -0.14 | | + Cancer fight, Medicine, Pharmaceutical
| + My List |
| CRDF | | Cardiff Oncology, Inc. - Common Stock | | | -2.76% down 10.59% -13.35 | | + Cancer fight, Medicine
Last highlighted: #CRDF SEC report: Cardiff Oncology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Cardiff Oncology, Inc. -- SEC File Number 211148042 | + My List |
| CRIS | | Curis, Inc. - Common Stock | | | 7.67% 7.67% 0 | | + Cancer fight, Medicine
| + My List |
| CSTL | | Castle Biosciences, Inc. - Common stock | | | -0.19% up -9.7% 9.51 | | + Cancer fight, Medicine
| + My List |
| CTMX | | CytomX Therapeutics, Inc. - Common Stock | | | -0.97% down 7.3% -8.27 | | + Biopharma, Cancer fight, Disease: Oncology
- Bad infrastructure
| + My List |
| CUE | | Cue Biopharma, Inc. - Common Stock | | | 0.46% up -8.54% 9 | | + Biopharma, Immunology, Cancer fight
| + My List |
| CYCCP | | Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | | | down 8.63% -8.63 | | + Cancer fight, Medicine, Biopharma
Last highlighted: Filing Alert, FORM 8-K [Press/News Current Report] available. $CYCC $CYCCP #CyclacelPharmaceuticals, Inc. https://t.co/wcEcOgiN2c | + My List |
| DCTH | | Delcath Systems, Inc. - Common Stock | | | -7.01% down -5.1% -1.91 | | + Cancer fight, Medicine, Disease: Liver
Last highlighted: #DCTH SEC report: DELCATH SYSTEMS, INC. Notice of Effectiveness | + My List |
| DMTK | | DermTech, Inc. - Common Stock | | | -0.55% up -7.32% 6.77 | | + Medicine, Cancer fight, Skin
Last highlighted: #DMTK SEC report: DermTech, Inc. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by DermTech, Inc. -- SEC File Number | + My List |
| DTIL | | Precision BioSciences, Inc. - Common Stock | | | -7.71% -7.71% 0 | | + Cancer fight, Gene and cell, Food
| + My List |
| ENOB | | Enochian Biosciences, Inc. - Common Stock | | | 1.37% up -7.77% 9.14 | | + Disease: Infectious, Cancer fight, Immunology, Medicine
| + My List |
| EPIX | | ESSA Pharma Inc. - Common Stock | | | -6.65% up -8.02% 1.37 | | + Pharmaceutical , Country: Canada, Cancer fight
Last highlighted: #EPIX SEC report: ESSA Pharma Inc. [Amend] Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G/A filed by ESSA Pharma Inc. -- SEC File Number 211182253 | + My List |
| EPZM | | Epizyme, Inc. - Common Stock | | | 0.46% 0.46% 0 | | + Cancer fight, Gene and cell
| + My List |
| FATE | | Fate Therapeutics, Inc. - Common Stock | | | 2.91% up -7.31% 10.22 | | + Cancer fight, Immunology, Medicine
| + My List |
| FGEN | | FibroGen, Inc - Common Stock | | | 6.12% down 8.27% -2.15 | | + Medicine, Cancer fight, Respiratory therapies / Pulmanory
| + My List |
| FLDM | | Fluidigm Corporation - Common Stock | | | 2.2% down 10.69% -8.49 | | + Life Sciences, Biology, Cancer fight, Biotechnology, RNA
Last highlighted: #FLDM SEC report: FLUIDIGM CORP Current report, items 1.01, 2.03, and 9.01
SEC Filing Form 8-K filed by FLUIDIGM CORP -- SEC File Number 211148270 | + My List |
| FPRX | | Five Prime Therapeutics, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight, Medicine
| + My List |
| FUSN | | Fusion Pharmaceuticals Inc. - Common Shares | | | 3.82% down 12.14% -8.32 | | + Pharmaceutical , Country: Canada, Medicine, Radiotherapy, Cancer fight
| + My List |
| GALT | | Galectin Therapeutics Inc. - Common Stock | | | 0.47% up -7.86% 8.33 | | + Cancer fight, Disease: Liver, Skin, Medicine
Last highlighted: #GALT SEC report: GALECTIN THERAPEUTICS INC Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by GALECTIN THERAPEUTICS INC -- SEC File Number 211081679 | + My List |
| GLSI | | Greenwich LifeSciences, Inc. - Common stock | | | 7.3% 7.3% 0 | | + Medicine, Biopharma, Cancer fight, Immunology
| + My List |
| GNCA | | Genocea Biosciences, Inc. - Common Stock | | | -7.89% -7.89% 0 | | + Cancer fight, Immunology, Medicine
| + My List |
| GNPX | | Genprex, Inc. - Common Stock | | | -3.11% up -15.27% 12.16 | | + Cancer fight, Disease: Oncology, Medicine
Last highlighted: $GNPX [15s. delayed] filed form 10-Q on August 13, 16:34:15 https://t.co/cEVufMKwcd | + My List |
| GOVX | | GeoVax Labs, Inc. - Common Stock | | | -11.18% up -13.74% 2.56 | | + Medicine, Cancer fight
| + My List |
| GRTS | | Gritstone Oncology, Inc. - Common Stock | | | -5.42% up -7.13% 1.71 | | + Medicine, Immunology, Cancer fight
| + My List |
| GTH | | Genetron Holdings Limited - American Depositary Shares | | | -5.59% up -8.28% 2.69 | | + Cancer fight, Medicine, Disease: Oncology, Country: China
Last highlighted: $GTH / Genetron Holdings Limited ADS files form 6-K https://t.co/3DehdripqL | + My List |
| HCM | | Hutchison China MediTech Limited - American Depositary Shares | | | -0.73% -0.73% 0 | | + Country: China, Medicine, Disease: Oncology, Cancer fight
Last highlighted: $HCM 📜 SEC Form 6-K filed by Hutchison China MediTech Limited
https://t.co/3MQ4DYnXFz
15s delayed. | + My List |
| HGEN | | Humanigen, Inc. - Common Stock | | | 3.3% up -13.66% 16.96 | | + Biopharma, Immunology, Cancer fight, Medicine
Last highlighted: #HGEN SEC report: HUMANIGEN, INC Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by HUMANIGEN, INC -- SEC File Number 211142187 | + My List |
| HOOK | | HOOKIPA Pharma Inc. - Common Stock | | | -6.97% up -8.61% 1.64 | | + Disease: Infectious, Immunology, Cancer fight, Medicine
| + My List |
| HTBX | | Heat Biologics, Inc. - Common Stock | | | 1.55% up -11.55% 13.1 | | + Medicine, Cancer fight
| + My List |
| ICAD | | icad inc. - Common Stock | | | -2.11% down 7.12% -9.23 | | + Medicine, Devices, Cancer fight
Last highlighted: #ICAD SEC report: ICAD INC Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ICAD INC -- SEC File Number | + My List |
| ILMN | | Illumina, Inc. - Common Stock | | | 0.35% down 9.18% -8.83 | | + Medicine, Gene and cell, Biology, Cancer fight, Reproductive health
Last highlighted: #ILMN SEC report: ILLUMINA, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by ILLUMINA, INC. -- SEC File Number 211148268 | + My List |
| IMMP | | Immutep Limited - American Depositary Shares | | | -6.02% up -7.08% 1.06 | | + Cancer fight, Medicine
| + My List |
| IMNM | | Immunome, Inc. - Common Stock | | | -6.44% up -7.14% 0.7 | | + Cancer fight, Biotechnology, Medicine, Immunology
| + My List |
| IMTX | | Immatics N.V. - Ordinary Shares | | | 1.85% down 7.12% -5.27 | | + Immunology, Cancer fight, Disease: Oncology, Medicine
| + My List |
| INFI | | Infinity Pharmaceuticals, Inc. - Common Stock | | | -3.33% up -9.09% 5.76 | | + Medicine, Cancer fight
Last highlighted: #INFI SEC report: INFINITY PHARMACEUTICALS, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by INFINITY PHARMACEUTICALS, INC. -- SEC File Number | + My List |
| INMB | | INmune Bio Inc. - Common stock | | | 7.06% 7.06% 0 | | + Immunology, Cancer fight, Disease: Oncology, Medicine
| + My List |
| IOVA | | Iovance Biotherapeutics, Inc. - Common Stock | | | -6.77% up -11.38% 4.61 | | + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based
Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127 | + My List |
| ITOS | | iTeos Therapeutics, Inc. - Common Stock | | | 2.37% 2.37% 0 | | + Cancer fight, Biopharma, Disease: Oncology, Immunology, Medicine
Last highlighted: $ITOS 📜 iTeos Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement
https://t.co/fsH6i8bthL
15s delayed. | + My List |
| JNCE | | Jounce Therapeutics, Inc. - Common Stock | | | -4.12% up -7.12% 3 | | + Immunology, Cancer fight, Medicine
| + My List |
| KPTI | | Karyopharm Therapeutics Inc. - Common Stock | | | -0.71% down 8.9% -9.61 | | + Cancer fight, Disease: Oncology, Pharmaceutical , Medicine
Last highlighted: #KPTI SEC report: Karyopharm Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Karyopharm Therapeutics Inc. -- SEC File Number | + My List |
| KRBP | | Kiromic BioPharma, Inc. - Common Stock | | | -7.43% -7.43% 0 | | + Biopharma, Cancer fight, Immunology, Medicine
Last highlighted: #KRBP SEC report: Kiromic Biopharma, Inc. Statement of acquisition of beneficial ownership by individuals | + My List |
| KTRA | | Kintara Therapeutics, Inc. - Common Stock | | | -9.62% down -7.69% -1.93 | | + Cancer fight, Medicine
| + My List |
| KURA | | Kura Oncology, Inc. - Common Stock | | | -6.61% up -7.09% 0.48 | | + Cancer fight, Medicine
Last highlighted: #KURA SEC report: Kura Oncology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Kura Oncology, Inc. -- SEC File Number 211148278 | + My List |
| MACK | | Merrimack Pharmaceuticals, Inc. - Common Stock | | | 8.14% 8.14% 0 | | + Pharmaceutical , Cancer fight, Medicine
| + My List |
| MBRX | | Moleculin Biotech, Inc. - Common Stock | | | -0.57% down 14.2% -14.77 | | + Biotechnology, Pharmaceutical , Medicine, Cancer fight, Disease: Infectious
Last highlighted: #MBRX SEC report: Moleculin Biotech, Inc. Statement of changes in beneficial ownership of securities | + My List |
| MGNX | | MacroGenics, Inc. - Common Stock | | | -4.21% up -7.32% 3.11 | | + Medicine, Cancer fight
| + My List |
| MGTA | | Magenta Therapeutics, Inc. - Common Stock | | | -1.72% up -9.69% 7.97 | | + Gene and cell, Cancer fight, Blood, Immunology, Medicine
Last highlighted: #MGTA SEC report: Magenta Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Magenta Therapeutics, Inc. -- SEC File Number 211084159 | + My List |
| MNPR | | Monopar Therapeutics Inc. - Common Stock | | | 3.2% down 7.83% -4.63 | | + Cancer fight, Medicine, Biopharma
Last highlighted: #MNPR SEC report: Monopar Therapeutics Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Monopar Therapeutics -- SEC File Number 211138054 | + My List |
| MOR | | MorphoSys AG - American Depositary Shares | | | -6.23% up -7.21% 0.98 | | + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight
| + My List |
| MREO | | Mereo BioPharma Group plc - American Depositary Shares | | | 7.97% 7.97% 0 | | + Biopharma, Cancer fight, Country: Greate Britain
Last highlighted: #MREO SEC report: Mereo Biopharma Group plc Registration statement by foreign private issuers
SEC Filing Form F-3 filed by Mereo Biopharma Group plc -- SEC File Number 211148904 | + My List |
| MRKR | | Marker Therapeutics, Inc. - Common Stock | | | up -7.77% 7.77 | | + Immunology, Medicine, Cancer fight
Last highlighted: #MRKR SEC report: Marker Therapeutics, Inc. Current report, items 7.01 and 9.01 | + My List |
| MRSN | | Mersana Therapeutics, Inc. - Common Stock | | | -5.91% up -8.03% 2.12 | | + Medicine, Cancer fight
Last highlighted: #MRSN SEC report: Mersana Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Mersana Therapeutics, Inc. -- SEC File Number | + My List |
| MRUS | | Merus N.V. - Common Shares | | | -2.01% down 9.24% -11.25 | | + Cancer fight, Medicine, Country: Netherlands
Last highlighted: #MRUS SEC report: Merus N.V. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Merus N.V. -- SEC File Number 211148220 | + My List |
| NCNA | | NuCana plc - American Depositary Shares | | | 10% 10% 0 | | + Cancer fight, Disease: Oncology, Medicine
| + My List |
| NH | | NantHealth, Inc. - Common Stock | | | -8.41% -8.41% 0 | | + Cancer fight, Medicine
- Bad infrastructure
| + My List |
| NK | | NantKwest, Inc. - Common Stock | | | 0.00% 0 | | + Cancer fight, Medicine, Immunology
- Bad infrastructure
| + My List |
| NRIX | | Nurix Therapeutics, Inc. - Common stock | | | -6.76% up -7.3% 0.54 | | + Biotechnology, Cancer fight, Immunology
Last highlighted: #NRIX SEC report: Nurix Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Nurix Therapeutics, Inc. -- SEC File Number 211088020 | + My List |
| NVCR | | NovoCure Limited - Ordinary Shares | | | 5.38% down 7.81% -2.43 | | + Cancer fight, Medicine
| + My List |
| ODT | | Odonate Therapeutics, Inc. - Common Stock | | | down 21.57% -21.57 | | + Cancer fight, Medicine
Last highlighted: #ODT SEC report: Odonate Therapeutics, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Odonate Therapeutics, Inc. -- SEC File Number 211148890 | + My List |
| ONCR | | Oncorus, Inc. - Common Stock | | | -7.31% down -6.6% -0.71 | | + Cancer fight, Immunology, Biotechnology
Last highlighted: #ONCR SEC report: Oncorus, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Oncorus, Inc. -- SEC File Number 211142316 | + My List |
| ONCS | | OncoSec Medical Incorporated - Common Stock | | | up -9.52% 9.52 | | + Cancer fight, Disease: Oncology, Medicine, Immunology
Last highlighted: #ONCS SEC report: ONCOSEC MEDICAL Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ONCOSEC MEDICAL Inc -- SEC File Number | + My List |
| ONCY | | Oncolytics Biotech Inc. - Common Shares | | | 7.28% 7.28% 0 | | + Medicine, Cancer fight, Country: Canada, Immunology
Last highlighted: $ONCY / Oncolytics Biotech files form 6-K https://t.co/G1byP6giz8 | + My List |
| ORIC | | Oric Pharmaceuticals, Inc. - Common Stock | | | -2.11% up -12.47% 10.36 | | + Pharmaceutical , Medicine, Disease: Oncology, Cancer fight
Last highlighted: #ORIC SEC report: Oric Pharmaceuticals, Inc. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Oric Pharmaceuticals, Inc. -- SEC File Number 211078899 | + My List |
| PDSB | | PDS Biotechnology Corporation - Common Stock | | | -3.28% up -7.1% 3.82 | | + Biotechnology, Immunology, Cancer fight, Disease: Oncology, Medicine
Last highlighted: RT @EdgarInsider: FORM 8-K [Press/News Current Report] recently SEC filed. $PDSB $EDGE PDS Biotechnology Corp https://t.co/FKxSQ3btJT | + My List |
| PHIO | | Phio Pharmaceuticals Corp. - Common Stock | | | -7% -7% 0 | | + Medicine, Cancer fight, Immunology
Last highlighted: #PHIO SEC report: Phio Pharmaceuticals Corp. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Phio Pharmaceuticals Corp. -- SEC File Number | + My List |
| PIRS | | Pieris Pharmaceuticals, Inc. - Common Stock | | | -6.39% up -7.67% 1.28 | | + Biopharma, Respiratory therapies / Pulmanory, Medicine, Immunology, Cancer fight
Last highlighted: #PIRS SEC report: PIERIS PHARMACEUTICALS, INC. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by PIERIS PHARMACEUTICALS, INC. -- SEC File Number 211142334 | + My List |
| PMVP | | PMV Pharmaceuticals, Inc. - Common Stock | | | 0.32% up -15.83% 16.15 | | + Medicine, Cancer fight, Pharmaceutical
Last highlighted: #PMVP SEC report: PMV Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by PMV Pharmaceuticals, Inc. -- SEC File Number | + My List |
| POAI | | Predictive Oncology Inc. - Common Stock | | | up -7% 7 | | + Cancer fight, Medicine, Artificial Intelligence
Last highlighted: #POAI SEC report: Predictive Oncology Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Predictive Oncology Inc. -- SEC File Number | + My List |
| PRLD | | Prelude Therapeutics Incorporated - Common Stock | | | -3.6% up -7.91% 4.31 | | + Cancer fight, Medicine
Last highlighted: #PRLD SEC report: Prelude Therapeutics Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Prelude Therapeutics Inc -- SEC File Number | + My List |
| PROG | | Progenity, Inc. - Common Stock | | | 10.19% 10.19% 0 | | + Gene and cell, Medicine, Cancer fight, Women Health
Last highlighted: #PROG SEC report: PROGENITY, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by PROGENITY, INC. -- SEC File Number | + My List |
| PSTV | | PLUS THERAPEUTICS, Inc. - Common Stock | | | 2% down 12% -10 | | + Cancer fight, Medicine, Radiotherapy
Last highlighted: #PSTV SEC report: PLUS THERAPEUTICS, INC. [Amend] Quarterly report [Sections 13 or 15(d)] | + My List |
| QTRX | | Quanterix Corporation - Common Stock | | | -0.06% up -7.07% 7.01 | | + Healthcare, Biology, Disease: Infectious, Disease: Cardiovascular, Cancer fight, Disease: Oncology
Last highlighted: #QTRX SEC report: Quanterix Corp Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Quanterix Corp -- SEC File Number | + My List |
| RAPT | | RAPT Therapeutics, Inc. - Common Stock | | | 1.67% up -14.21% 15.88 | | + Cancer fight, Medicine
Last highlighted: #RAPT SEC report: RAPT Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by RAPT Therapeutics, Inc. -- SEC File Number | + My List |
| REPL | | Replimune Group, Inc. - Common Stock | | | 2.62% 2.62% 0 | | + Cancer fight
Last highlighted: #REPL SEC report: Replimune Group, Inc. [Amend] Statement of changes in beneficial ownership of securities
SEC Filing Form 4/A filed by Replimune Group, Inc. -- SEC File Number | + My List |
| RIGL | | Rigel Pharmaceuticals, Inc. - Common Stock | | | 0.76% down 9.5% -8.74 | | + Medicine, Cancer fight
| + My List |
| RUBY | | Rubius Therapeutics, Inc. - Common Stock | | | -1.35% down 7.22% -8.57 | | + Gene and cell, Cancer fight, Medicine
| + My List |
| RVMD | | Revolution Medicines, Inc. - Common Stock | | | 6.34% down 8.21% -1.87 | | + Cancer fight, Medicine, Biotechnology
| + My List |
| SESN | | Sesen Bio, Inc. - Common Stock | | | up -18.35% 18.35 | | + Cancer fight, Medicine
Last highlighted: #SESN SEC report: Sesen Bio, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Sesen Bio, Inc. -- SEC File Number 211102791 | + My List |
| SLRX | | Salarius Pharmaceuticals, Inc. - Common Stock | | | 0 | | + Cancer fight, Biotechnology, Medicine, Pharmaceutical
Last highlighted: $SLRX 8-K Salarius Pharmaceuticals (8 Mar, 4:30pm)
📰 Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
https://t.co/AWdEx2wgvD
#SLRX #8K #SalariusPharmaceuticals #News | + My List |
| SLS | | SELLAS Life Sciences Group, Inc. - Common Stock | | | 1.3% up -7.07% 8.37 | | + Cancer fight, Medicine
Last highlighted: SELLAS Announces Positive Follow-up Data from the Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In-Situ of the Breast
https://www.sellaslifesciences.com/investors/news/News-Details/2020/SELLAS-Announces-Positive-Follow-up-Data-from-the-Randomized-Phase-2-VADIS-Trial-of-Nelipepimut-S-NPS-in-Women-with-Ductal-Carcinoma-In-Situ-of-the-Breast/default.aspx | + My List |
| SNSS | | Sunesis Pharmaceuticals, Inc. - Common Stock | | | 0.00% 0 | | + Medicine, Biopharma, Cancer fight
| + My List |
| SONN | | Sonnet BioTherapeutics Holdings, Inc. - Common Stock | | | -45.05% down -44.14% -0.91 | | + Cancer fight, Biology, Medicine
| + My List |
| SRNE | | Sorrento Therapeutics, Inc. - Common Stock | | | 7.16% up 6.29% 0.87 | | + Pain fight, Cancer fight, Medicine
| + My List |
| STRO | | Sutro Biopharma, Inc. - Common Stock | | | 0.68% up -10.83% 11.51 | | + Cancer fight, Medicine
| + My List |
| SURF | | Surface Oncology, Inc. - Common Stock | | | -4.16% up -8.05% 3.89 | | + Cancer fight, Immunology, Medicine
Last highlighted: #SURF SEC report: Surface Oncology, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Surface Oncology, Inc. -- SEC File Number 211078938 | + My List |
| SYRS | | Syros Pharmaceuticals, Inc. - common stock | | | -6.62% up -12.25% 5.63 | | + Gene and cell, Medicine, Cancer fight
| + My List |
| TARA | | Protara Therapeutics, Inc. - Common Stock | | | 8.95% 8.95% 0 | | + Cancer fight, Medicine
| + My List |
| TCON | | TRACON Pharmaceuticals, Inc. - Common Stock | | | 7.2% 7.2% 0 | | + Pharmaceutical , Cancer fight, Medicine, Biopharma, Disease: Oncology
| + My List |
| TCRR | | TCR2 Therapeutics Inc. - Common Stock | | | -7.06% up -7.73% 0.67 | | + Cancer fight, Medicine
| + My List |
| THTX | | Theratechnologies Inc. - Common Shares | | | -2.17% down 11.67% -13.84 | | + Cancer fight, Biopharma, Medicine
| + My List |
| TRIL | | Trillium Therapeutics Inc. - Common Shares | | | 189.49% down 189.66% -0.16999999999999 | | + Country: Canada, Cancer fight, Disease: Oncology, Immunology
Last highlighted: #TRIL SEC report: Trillium Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Trillium Therapeutics Inc. -- SEC File Number | + My List |
| TTOO | | T2 Biosystems, Inc. - Common Stock | | | -7% down -6% -1 | | + Medicine, Cancer fight
Last highlighted: #TTOO SEC report: T2 Biosystems, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by T2 Biosystems, Inc. -- SEC File Number | + My List |
| TYME | | Tyme Technologies, Inc. - Common Stock | | | 4.67% down 12.15% -7.48 | | + Cancer fight, Medicine
Last highlighted: #TYME SEC report: TYME TECHNOLOGIES, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by TYME TECHNOLOGIES, INC. -- SEC File Number | + My List |
| VBLT | | Vascular Biogenics Ltd. - Ordinary Shares | | | -8.12% down -6.09% -2.03 | | + Country: Israel, Biopharma, Cancer fight, Medicine
| + My List |
| VERU | | Veru Inc. - Common Stock | | | -3.44% down 13.76% -17.2 | | + Cancer fight, Medicine
Last highlighted: Veru, Inc. (VERU) CEO Mitchell Steiner on Q4 2020 Results - Earnings Call Transcript | + My List |
| VRAY | | ViewRay, Inc. - Common Stock | | | 5.65% down 8.82% -3.17 | | + Cancer fight, Radiotherapy, Medicine
Last highlighted: #VRAY SEC report: ViewRay, Inc. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by ViewRay, Inc. -- SEC File Number 211148242 | + My List |
| VSTM | | Verastem, Inc. - Common Stock | | | 8.19% up 5.26% 2.93 | | + Biopharma, Cancer fight, Medicine
Last highlighted: #VSTM SEC report: Verastem, Inc. Automatic shelf registration statement of securities of well-known seasoned issuers
SEC Filing Form S-3ASR filed by Verastem, Inc. -- SEC File Number 211136620 | + My List |
| XBIO | | Xenetic Biosciences, Inc. - Common Stock | | | -0.73% down 7.03% -7.76 | | + Biopharma, Cancer fight, Disease: Oncology, Medicine
| + My List |
| XFOR | | X4 Pharmaceuticals, Inc. - Common Stock | | | 6.7% down 7.66% -0.96 | | + Cancer fight, Medicine, Pharmaceutical
Last highlighted: #XFOR SEC report: X4 Pharmaceuticals, Inc Current report, item 2.02
SEC Filing Form 8-K filed by X4 Pharmaceuticals, Inc -- SEC File Number 211138073 | + My List |
| YMAB | | Y-mAbs Therapeutics, Inc. - Common Stock | | | -6.29% up -7.09% 0.8 | | + Biopharma, Cancer fight, Medicine
Last highlighted: #YMAB SEC report: Y-mAbs Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Y-mAbs Therapeutics, Inc. -- SEC File Number 211148421 | + My List |
| ZIOP | | ZIOPHARM Oncology Inc - Common Stock | | | -8.18% -8.18% 0 | | + T cell-based, Cancer fight, Disease: Oncology, Immunology, Medicine
| + My List |
| ZNTL | | Zentalis Pharmaceuticals, Inc. - common stock | | | -7.19% down -6% -1.19 | | + Cancer fight, Biology, Pharmaceutical , Medicine
Last highlighted: #ZNTL SEC report: Zentalis Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Zentalis Pharmaceuticals, Inc. -- SEC File Number | + My List |
| BCTX | | BriaCell Therapeutics Corp. - Common Shares | | | 7.07% up 3.41% 3.66 | | + Cancer fight, Immunology, Medicine, Disease: Oncology
Last highlighted: #BCTX SEC report: BriaCell Therapeutics Corp. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BriaCell Therapeutics Corp. -- SEC File Number 211182540 | + My List |
| BOLT | | Bolt Biotherapeutics, Inc. - Common Stock | | | -7.24% down -4.83% -2.41 | | + Immunology, Cancer fight, Disease: Oncology, Medicine
| + My List |
| ENVB | | Enveric Biosciences, Inc. - Common Stock | | | -10.68% -10.68% 0 | | + Biotechnology, Cancer fight, Medicine, Cannabis, Disease: Oncology
Last highlighted: #ENVB SEC report: Enveric Biosciences, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Enveric Biosciences, Inc. -- SEC File Number 211084155 | + My List |
| EVAX | | Evaxion Biotech A/S - American Depositary Share | | | -7.14% down -5.99% -1.15 | | + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology
Last highlighted: #EVAX SEC report: Evaxion Biotech A/S Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evaxion Biotech A/S -- SEC File Number 211078935 | + My List |
| FSTX | | F-star Therapeutics, Inc. - Common Stock | | | -8.33% -8.33% 0 | | + Immunology, Medicine, Cancer fight, Disease: Oncology
Last highlighted: #FSTX SEC report: F-star Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by F-star Therapeutics, Inc. -- SEC File Number | + My List |
| GTBP | | GT Biopharma, Inc. - Common Stock | | | -6.25% up -8.75% 2.5 | | + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight
Last highlighted: #GTBP SEC report: GT Biopharma, Inc. Notification of inability to timely file Form 10-Q or 10-QSB
SEC Filing Form NT 10-Q filed by GT Biopharma, Inc. -- SEC File Number 211181131 | + My List |
| LIXT | | Lixte Biotechnology Holdings, Inc. - Common Stock | | | -9.26% -9.26% 0 | | + Biotechnology, Cancer fight, Disease: Oncology, Medicine
Last highlighted: #LIXT SEC report: LIXTE BIOTECHNOLOGY HOLDINGS, INC. Current report, item 5.07
SEC Filing Form 8-K filed by LIXTE BIOTECHNOLOGY HOLDINGS, INC. -- SEC File Number 211083663 | + My List |
| OCX | | OncoCyte Corporation - Common Stock | | | -7.28% down -4.85% -2.43 | | + Cancer fight, Diagnosing, Medicine
Last highlighted: #OCX SEC report: OncoCyte Corp Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by OncoCyte Corp -- SEC File Number 211160996 | + My List |
| PPBT | | Purple Biotech Ltd. - American Depositary Shares | | | 8.5% up 7.96% 0.54 | | + Country: Israel, Cancer fight, Disease: Oncology
| + My List |
| PRTG | | Portage Biotech Inc. - Common Stock | | | 8.65% up 2.77% 5.88 | | + Country: Canada, Immunology, Cancer fight, Disease: Oncology
| + My List |
| SBTX | | Silverback Therapeutics, Inc. - Common Stock | | | -7.44% -7.44% 0 | | + Cancer fight, Disease: Oncology, Disease: Infectious, Medicine
| + My List |
| SCPS | | Scopus BioPharma Inc. - Common Stock | | | -6.67% up -7.33% 0.66 | | + Immunology, Cancer fight, Medicine, Disease: Oncology, Biopharma
Last highlighted: Alert [Quarterly Report] / Form 10-Q filed with the SEC $SCPS Scopus BioPharma Inc. Scopus BioPharma Inc https://t.co/lmBK4v1IJB | + My List |
| VOR | | Vor Biopharma Inc. - Common Stock | | | 9.78% 9.78% 0 | | + Biopharma, Medicine, Cancer fight, Disease: Oncology
| + My List |
| IKNA | | Ikena Oncology, Inc. - Common Stock | | | -11% -11% 0 | | + Cancer fight, Disease: Oncology, Medicine
| + My List |
| LVTX | | LAVA Therapeutics N.V. - Ordinary Shares | | | -7.05% down -4.19% -2.86 | | + T cell-based, Cancer fight, Medicine, Disease: Oncology
| + My List |